(Q39298225)

10 September 2017

title

Proton pump inhibitors in the management of GERD. (English)

1 reference

10 September 2017

Philip O Katz

1

1 reference

10 September 2017

Stacey Zavala

series ordinal

2

1 reference

10 September 2017

publication date

23 September 2009

1 reference

Journal of Gastrointestinal Surgery

10 September 2017

published in

1 reference

10 September 2017

volume

14 Suppl 1

1 reference

10 September 2017

page(s)

S62-6

1 reference

Use of proton pump inhibitors and risk of osteoporosis-related fractures

10 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11605-009-1015-3

21 January 2018

1 reference

12 December 2020

Proton pump inhibitors: better acid suppression when taken before a meal than without a meal

1 reference

12 December 2020

Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms

1 reference

12 December 2020

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

1 reference

12 December 2020

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

1 reference

12 December 2020

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

1 reference

12 December 2020

Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis

1 reference

12 December 2020

Pharmacological Management of Gastro-Oesophageal Reflux Disease

1 reference

12 December 2020

Extraesophageal gastroesophageal reflux disease. Presentations and approach to treatment

1 reference

12 December 2020

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

1 reference

12 December 2020

Helicobacter pylori infection influences nocturnal gastric acid breakthrough

1 reference

12 December 2020

Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.

1 reference

12 December 2020

Omeprazole: a comprehensive review

1 reference

12 December 2020

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

1 reference

12 December 2020

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

1 reference

12 December 2020

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

12 December 2020

Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST).

1 reference

12 December 2020

Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily

1 reference

12 December 2020

Review article: pharmacokinetic concerns in the selection of anti-ulcer therapy

1 reference

12 December 2020

Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease

1 reference

12 December 2020

Review article: proton pump inhibitors and bacterial overgrowth

1 reference

12 December 2020

A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study

1 reference

12 December 2020

Review article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia

1 reference

12 December 2020

Vitamin B12 levels during prolonged treatment with proton pump inhibitors

1 reference

12 December 2020

Long-term proton pump inhibitor therapy and risk of hip fracture

1 reference

12 December 2020

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

1 reference

12 December 2020

10.1007/S11605-009-1015-3

Identifiers

DOI

1 reference

10 September 2017

1 reference